Healthcare industry-focused artificial intelligence (AI) startup Opmed.ai has raised $15 million in Series A funding to develop its AI-driven software, which is designed to optimise the operational capacity of operating rooms (ORs).
The funding was led by several investors which included NFX and Grove Ventures, alongside Secret Chord Ventures, the impact investor Sir Ronald Cohen, and Unbox Ventures, reports CTech.
“This round marks a significant milestone in that it provides us with the ability to rapidly scale an innovative technology, which has demonstrated success since 2021 and meet the demand that we’re already seeing from hospitals across the US,” said Dr. Mor Brokman Meltzer, Co-Founder and CEO of Opmed.ai.
“Our mission is to support hospitals grappling with staff shortages and other critical issues by providing them a less labour-intensive, more effective way to perform at their best, and that’s exactly what this round will enable us to accomplish,” he added.
Through the application of advanced AI technology, Opmed.ai optimises healthcare operations, starting with operating rooms. The company’s optimisation engine runs billions of permutations in seconds and predicts based on factors specific to each industry, automatically generating alternative schedules that improve resource allocation.
According to the report, the Opmed.ai platform is already being used by leading hospitals across the US and in Israel, and is collaborating with leading healthcare organisations such as Mayo Clinic.
“Opmed.ai is a perfect representation of the next generation of great AI platforms. They solve a complex issue with a highly specialised vertical solution that has no alternative that comes close,” said Renana Ashkenazi, General Partner of Grove Ventures.
The company is co-founded by Meltzer, Avi Paz, and Professor Baruch Barzel. It employs around 30 people — 20 in Israel and the rest in the US.